CastleArk Management »

Halozyme Therapeutics shares owned by CastleArk Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by CastleArk Management from 13F filings

Historical chart of CastleArk Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by CastleArk Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by CastleArk Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.3M 116k 36.96
2023-09-30 $4.9M 128k 38.20
2022-12-31 $12M 206k 56.90
2022-09-30 $8.6M 217k 39.54
2022-06-30 $9.0M 204k 44.00
2021-09-30 $8.9M 220k 40.68
2021-06-30 $14M 318k 45.41
2021-03-31 $18M 431k 41.69
2020-12-31 $21M 499k 42.71
2020-09-30 $16M 599k 26.28
2020-06-30 $15M 561k 26.81
2020-03-31 $7.9M 438k 17.99
2018-06-30 $7.1M 423k 16.87
2018-03-31 $8.5M 433k 19.59
2017-12-31 $7.1M 350k 20.26
2017-09-30 $4.0M 233k 17.37